ARMS 2019 ADELAIDE

Keynote/Invited Speakers

The Conference Convenors and Program Committee are working to develop a program that will feature a range of engaging keynote and invited speakers. Watch this space for the latest speaker updates and information!

Keynote Speakers

Catherine Wood

Chief Executive Officer/Chief Investment Officer, ARK Invest

Cathie registered ARK Investment Management LLC (“ARK”) as an investment adviser with the U.S. Securities and Exchange Commission in January 2014. Focused solely on disruptive innovation, ARK aims to identify large-scale investment opportunities in the public markets resulting from technological innovations centered around genome sequencing, robotics, artificial intelligence, energy storage, and blockchain technology. Prior to ARK, Cathie spent twelve years at AllianceBernstein as Chief Investment Officer of Global Thematic Strategies where she managed over $5 billion. Cathie joined Alliance Capital from Tupelo Capital Management, a hedge fund she co-founded which, in 2000, managed $800 million in global thematic strategies. Prior to her tenure at Tupelo Capital, she worked for 18 years with Jennison Associates as Chief Economist, Equity Research Analyst, Portfolio Manager and Director. She started her career in Los Angeles, California at The Capital Group as an Assistant Economist. Cathie received her Bachelor of Science, summa cum laude, in Finance and Economics from the University of Southern California in 1981. In 2018, editors at Bloomberg acknowledged Cathie by selecting her to its second annual Bloomberg 50 list of people across business, entertainment, finance, politics, technology, and science who have defined global business. Additionally, Fortune named Cathie to its exclusive roundtable of experts in the annual Fortune Investors Guide: The Best Investing Advice for 2019 From Fortune’s Experts. In 2016, Cathie received the “Women in Finance – Outstanding Contribution Award” from Market Media, and she was a featured speaker at the World Economic Forum (China) in 2016 & 2017, and the World Strategic Forum (Miami) in 2017. www.ark-invest.com

Sue MacLeman

Chair and Non-Executive Director, MTPConnect

Sue MacLeman has more than 30 years’ experience as a pharmaceutical, biotechnology and medical technology executive having held senior roles in corporate, medical, commercial and business development. Sue has also served as CEO and Board member of several ASX and NASDAQ listed companies in the pharmaceutical sector and is currently Chair of MTPConnect (MTPII-GC Ltd), Chair of Anatara Lifesciences Ltd (ASX:ANR), Chair of Novita Healthcare Ltd (ASX:NHL), Non-Executive Director of TPI Enterprises Ltd (ASX:TPE), Non-Executive Director of Oventus Medical Ltd (ASX:OVN) and Non-Executive Director of veski. Sue is also appointed to several academic and government advisory committees.

Professor Lisa Bero PhD

Chair of Medicines Use and Health Outcomes, Charles Perkins Centre, The University of Sydney

Lisa A. Bero, PhD is an expert in examining how science can be influenced and translated into clinical practice and health policy.  She directs the Evidence, Policy and Influence Collaborative Research Program at the Charles Perkins Centre, with Research nodes in Bias, Evidence Synthesis and Pharmaceutical Policy.  Professor Bero is Chair of Medicines Use and Health Outcomes, Faculty of Medicine and Health, School of Pharmacy, The University of Sydney.  She was Co-Chair, The Cochrane Collaboration, from 2014-2018.  She has developed and validated methods for assessing bias in the design, conduct and dissemination of research on pharmaceuticals, tobacco, chemicals, and complex public health interventions.  Prof. Bero has also conducted analyses to examine the dissemination and policy implications of research evidence.  Her international activities include member and chair of the World Health Organization (WHO) Essential Medicines Committee and Cochrane Collaboration liaison to WHO.  Prof. Bero serves on several committees related to conflicts of interest, evidence and decisions, such as the Institute of Medicine Committee on Conflict of Interest in Medical Research, Education and Practice and the National Academy of Science Committee to review the Environmental Protection Agency Integrated Risk Information System Process.

Dr Andy Cope

Art of Brilliance

Dr Andy Cope describes himself as a qualified teacher, author, happiness expert and recovering academic. Andy’s Loughborough University PhD was 12 years in the making and while he appreciates that his ‘Dr of Happiness’ label is terribly cheesy it does afford him an important media platform. In times of rising depression and an epidemic of ‘busyness’, Andy believes there has never been a more appropriate time to raise the wellbeing agenda. Andy is lucky enough to work with some very large businesses, including Microsoft, DHL, Kellogg, Hewlett Packard, Astra Zeneca and Marriott Hotels. Recently, he has tailored his workshops to meet the needs of children and teachers and now delivers to audiences from age 8 upwards! Andy is also a best-selling author. ‘The Art of Being Brilliant’, ‘Shine’, ‘The Little Book of Emotional Intelligence’ and ‘Leadership: The Multiplier Effect’ have all been best-sellers. ‘Happiness Route Map’ was nominated as The Independent’s best self-help book of 2018. In an attempt to bring the messages to a younger audience Andy has also penned ‘The Art of Being a Brilliant Teenager’ and ‘Diary of a Brilliant Kid’. ‘The Little Book of Being Brilliant’ is scheduled for release in Spring 2019. Andy is a sought-after keynote speaker and authority on employee engagement, wellbeing and human flourishing. He’s done numerous TV and radio appearances as well as being featured in The Telegraph, Daily Mail and Esquire. As for genuinely interesting asides, Andy is also a best-selling children’s author. His ‘Spy Dog’ series has sold in excess of a million copies worldwide (he bigs himself up by telling everyone he is world famous, if you’re 7) Andy was born in the same year that England won the football world cup, he has pet pigs and has set up the hugely successful 2%ers club, the UK’s first, foremost and...err...only society for happy people. His ambition is to be able to surf, brilliantly! www.artofbrilliance.co.uk

Invited Speakers

Professor Joe Luca

Dean, Graduate Research School, Edith Cowan University

Professor Joe Luca is the Dean of the Graduate Research School at Edith Cowan University. His research focus is on developing quality doctoral programs encompassing supervisory practice and training programs, industry engagement, developing impact, online delivery, admission and administration processes, mobility, international collaboration, research climate, candidate support services, professional skills and career development. Professor Luca will be taking part of the Deans of Graduate Research Panel at the Conference on Friday 20th September. 

Dr Cathy Foley

CSIRO Chief Scientist

Dr Cathy Foley, CSIRO Chief Scientist, has made distinguished contributions to the understanding of superconducting materials and to the development of devices using superconductors to detect magnetic fields and locate valuable deposits of minerals. Dr Foley has made significant contributions to the scientific community as president of several scientific societies and as a member of committees such as PMSEIC giving advice to Government on scientific and technological matters.  Cathy was awarded the `Woman of the Year’ by the NSW Government in 2013 and the International IEEE Award for Continuing and Significant Contributions to Applied Superconductivity 2014. In 2015 was awarded the Clunies Ross Medal of the Australian Academy of Technological Science and Engineering and in 2016 the Australian Institute of Physics  Medal for Outstanding Service to Physics. As a leader in CSIRO, Cathy is working to help existing Australia to transform to be globally competitive by engaging with Australian researchers and to build new companies and enterprises to assist with the translation of research for economic prosperity. Dr Foley will be taking part of the Chief Scientist Panel at the Conference on Thursday 19th September.